Your browser is no longer supported. Please, upgrade your browser.
Settings
SGYP Synergy Pharmaceuticals Inc. daily Stock Chart
SGYP [NASD]
Synergy Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.16 Insider Own0.94% Shs Outstand233.29M Perf Week-0.83%
Market Cap559.90M Forward P/E- EPS next Y-0.65 Insider Trans-79.94% Shs Float233.29M Perf Month20.00%
Income-247.20M PEG- EPS next Q-0.19 Inst Own62.20% Short Float32.38% Perf Quarter-16.67%
Sales7.40M P/S75.66 EPS this Y-8.50% Inst Trans-0.16% Short Ratio10.30 Perf Half Y-43.79%
Book/sh-0.01 P/B- EPS next Y37.50% ROA-195.90% Target Price7.56 Perf Year-62.56%
Cash/sh- P/C- EPS next 5Y- ROE-540.20% 52W Range1.68 - 7.15 Perf YTD7.62%
Dividend- P/FCF- EPS past 5Y-31.80% ROI- 52W High-66.43% Beta1.20
Dividend %- Quick Ratio3.90 Sales past 5Y- Gross Margin7.60% 52W Low42.86% ATR0.16
Employees116 Current Ratio4.30 Sales Q/Q- Oper. Margin- RSI (14)58.98 Volatility6.85% 7.26%
OptionableYes Debt/Eq- EPS Q/Q2.90% Profit Margin- Rel Volume0.74 Prev Close2.27
ShortableYes LT Debt/Eq- EarningsFeb 28 AMC Payout- Avg Volume7.33M Price2.40
Recom2.30 SMA204.71% SMA509.81% SMA200-26.67% Volume5,399,980 Change5.73%
Jan-05-18Downgrade Oppenheimer Outperform → Perform
Sep-25-17Reiterated H.C. Wainwright Buy $15 → $8
Sep-13-17Reiterated Citigroup Sell $3.20 → $2.50
Sep-08-17Reiterated Oppenheimer Outperform $9 → $6
Aug-10-17Reiterated Rodman & Renshaw Buy $18 → $15
Apr-06-17Downgrade Citigroup Neutral → Sell
Jan-20-17Reiterated Rodman & Renshaw Buy $17 → $18
Jan-05-17Initiated Oppenheimer Outperform
Dec-23-16Reiterated Rodman & Renshaw Buy $16 → $17
Dec-18-15Downgrade Citigroup Buy → Neutral
Oct-29-15Resumed ROTH Capital Buy $9.50
Jun-18-15Reiterated Canaccord Genuity Buy $11 → $19
May-22-15Initiated Canaccord Genuity Buy $11
Nov-18-14Reiterated ROTH Capital Buy $8.50 → $6
Aug-12-13Reiterated Cantor Fitzgerald Buy $15 → $11
Apr-09-13Reiterated Cantor Fitzgerald Buy $12 → $15
Jan-02-13Reiterated Cantor Fitzgerald Buy $7 → $13
Sep-25-12Initiated Cantor Fitzgerald Buy $7
Jan-10-18 01:36PM  Bet Against Synergy Pharmaceuticals Inc Stock Has Paid off for Now InvestorPlace
Jan-08-18 08:10AM  Todays Research Reports on Trending Tickers: Amicus Therapeutics, Inc. and Synergy Pharmaceuticals, Inc. ACCESSWIRE
Jan-05-18 02:41PM  A Dilutive Offering In The Offing? Oppenheimer Downgrades Synergy Pharma Benzinga -10.66%
11:43AM  Dilution Fears Continue to Hit Synergy Pharmaceuticals Inc (SGYP); Oppenheimer Downgrades the Stock SmarterAnalyst
Jan-04-18 02:20PM  Tim Chiang Upbeat on These Two Biotech Players Circling FDA Approvals in 2018: Synergy Pharmaceuticals Inc., Progenics Pharmaceuticals SmarterAnalyst
Jan-03-18 09:28AM  The Zacks Analyst Blog Highlights: Synergy Pharmaceuticals, Aradigm and Sucampo Pharmaceuticals Zacks
Jan-02-18 08:07AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit +9.87%
08:04AM  3 Biotech and Pharma Stocks with FDA Catalysts this January Zacks
Dec-26-17 01:10PM  Synergy Pharmaceuticals, Inc. Value Analysis (NASDAQ:SGYP) : December 26, 2017 Capital Cube
Dec-25-17 07:43AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SGYP-US : December 25, 2017 Capital Cube
Dec-20-17 10:26AM  Edited Transcript of SGYP earnings conference call or presentation 9-Nov-17 9:30pm GMT Thomson Reuters StreetEvents +9.76%
Dec-19-17 11:38AM  Synergy Pharmaceuticals (SGYP) Shares Pop on New CEO Pick SmarterAnalyst
09:00AM  Synergy Pharmaceuticals Appoints Troy Hamilton Chief Executive Officer Business Wire
Dec-15-17 09:48PM  SYNERGY PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Synergy Pharmaceuticals, Inc. To Contact The Firm PR Newswire
Dec-12-17 05:48PM  John Paulson Reduces Synergy Pharmaceuticals After Heavy 3rd Quarter Health Care Selling GuruFocus.com
08:05AM  Synergy Pharmaceuticals: Analyst's View, January PDUFA Date and Pipeline Review ACCESSWIRE
Dec-10-17 07:16PM  2018 Is a Critical Year for These 3 Small Commercial-Stage Biotech Stocks Motley Fool
Dec-08-17 07:58AM  With FDA Approvals in Sight, Will Synergy Pharmaceuticals and Agile Therapeutics Skyrocket as H.C Wainwright Predicts? SmarterAnalyst
Nov-27-17 08:07AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit
Nov-22-17 07:34AM  Synergy Pharmaceuticals Is Facing These Risks This November Market Realist
Nov-21-17 05:05PM  Behind Synergy Pharmaceuticals Financials Today Market Realist
03:35PM  An Overview of Trulance: Synergy Pharmaceuticals First Commercialized Drug Market Realist
02:01PM  Inside Synergy Pharmaceuticals: Your Investor Overview Market Realist
08:47AM  This $12 Billion Hedge Fund Is Switching to Synergy Pharmaceuticals, Away from ACADIA Investopedia
08:08AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit
Nov-17-17 08:05AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit
Nov-15-17 12:50PM  Synergy Pharmaceuticals: Should You Buy the Dip Ahead of FDA Approval? SmarterAnalyst -6.90%
08:05AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit
Nov-14-17 02:54PM  Here's What's Behind Synergy Pharmaceuticals' 15.6% Drop Today Motley Fool -16.80%
Nov-13-17 10:47AM  BTIG Suggests One Stock to Buy and One to Proceed with Caution SmarterAnalyst -10.29%
09:27AM  Synergy Pharmaceuticals Announces Pricing of Offering of Common Stock and Warrants Business Wire
08:10AM  Todays Research Reports on Stocks to Watch: Infinity Pharmaceuticals and Synergy Pharmaceuticals ACCESSWIRE
Nov-12-17 12:00PM  5 Small Biotechs Receive Shots in the Arm TheStreet.com
Nov-10-17 01:32PM  Canaccords Confident Take: Synergy Pharmaceuticals Could See Exciting Commercial Potential Boost Come 2018 SmarterAnalyst -8.42%
08:13AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit
Nov-09-17 06:18PM  Synergy Pharma reports 3Q loss Associated Press
04:00PM  Synergy Pharmaceuticals Reports Third Quarter 2017 Financial Results and Business Update Business Wire
12:30PM  Synergy Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Nov-06-17 08:20AM  Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pharma, National Oilwell Varco, Ironwood Pharma, Express Scripts, and Synergy Pharma Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
07:16AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SGYP-US : November 6, 2017 Capital Cube
Nov-01-17 08:30AM  Synergy Pharmaceuticals to Report Third Quarter 2017 Financial Results and Host Conference Call and Webcast Business Wire
Oct-26-17 12:24PM  Synergy Pharmaceuticals Inc (SGYP): A 2018 Story Shapes Up SmarterAnalyst
Oct-25-17 11:36AM  3 Biotech Stocks to Consider Ahead of FDA Decisions Investopedia
Oct-19-17 08:15AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SGYP-US : October 19, 2017 Capital Cube
Oct-18-17 02:20PM  H.C. Wainwright Pounds the Table on Synergy Pharmaceuticals Inc (SGYP) SmarterAnalyst
Oct-17-17 10:30AM  Synergy Pharmaceuticals Presents Results from Study Examining Patient and Physician Perceptions and Experiences with Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire
Oct-12-17 09:30AM  Synergy Pharmaceuticals to Highlight New Data for TRULANCE® (Plecanatide) at the World Congress of Gastroenterology (WCOG) at American College of Gastroenterology (ACG) Business Wire
Oct-04-17 11:27AM  Synergy Pharmaceuticals, Inc. Value Analysis (NASDAQ:SGYP) : October 4, 2017 Capital Cube +6.50%
Oct-03-17 08:33AM  Synergy Pharmaceuticals (SGYP) Surges: Stock Moves 12.1% Higher Zacks
08:15AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SGYP-US : October 3, 2017 Capital Cube
Oct-02-17 08:06AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit +12.07%
08:00AM  Today's Research Reports on Trending Tickers: Synergy Pharmaceuticals and Jaguar Health ACCESSWIRE
Sep-29-17 05:15PM  Why Synergy Pharmaceuticals Rallied 12% Today Motley Fool +11.97%
Sep-26-17 01:43PM  Analysts Take Action on Health Care Stocks GuruFocus.com
08:04AM  See what the IHS Markit Score report has to say about Synergy Pharmaceuticals Inc. Markit
Sep-21-17 07:54PM  CORRECTING and REPLACING Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences Business Wire
Sep-08-17 09:45PM  Edited Transcript of SGYP earnings conference call or presentation 7-Sep-17 8:30pm GMT Thomson Reuters StreetEvents -7.31%
Sep-06-17 08:30AM  Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences Business Wire
08:00AM  2017 is a Transformative Year for Synergy, Q2 Review, and Analyst Outlook ACCESSWIRE
Sep-05-17 08:30AM  Synergy Pharmaceuticals Secures $300 Million Debt Financing Business Wire
Aug-11-17 08:40PM  Synergy Pharmaceuticals, Inc. Value Analysis (NASDAQ:SGYP) : August 12, 2017 Capital Cube
Aug-10-17 11:19AM  Here's Why Synergy Pharmaceuticals Inc. Is Falling Today Motley Fool -13.03%
08:05AM  IHS Markit Score Update: Drop in demand for ETFs holding Synergy Pharmaceuticals Inc is a negative sign for its shares Markit
Aug-09-17 04:30PM  Synergy Pharmaceuticals Reports Second Quarter 2017 Financial Results and Business Update Business Wire
Aug-08-17 02:58PM  Synergy Pharmaceuticals Inc. Tanked 14.2% in July -- but Why? Motley Fool -7.27%
Jul-28-17 09:35AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SGYP-US : July 28, 2017 Capital Cube
Jul-25-17 01:11PM  ETFs with exposure to Synergy Pharmaceuticals, Inc. : July 25, 2017 Capital Cube
Jul-24-17 07:09PM  ETFs with exposure to Synergy Pharmaceuticals, Inc. : July 24, 2017 Capital Cube
Jul-14-17 04:48PM  ETFs with exposure to Synergy Pharmaceuticals, Inc. : July 14, 2017 Capital Cube
Jul-13-17 04:07PM  What To Expect Ahead of Synergy Pharmaceuticals Inc (SGYP) 2Q Earnings; Oppenheimers Take SmarterAnalyst
Jul-10-17 01:41PM  Synergy Pharmaceuticals Inc (SGYP) Trulance Poses Enticing Long-Term Uptake SmarterAnalyst
Jun-27-17 11:55AM  Healthcare Guru Samuel Isaly Plays Two Key Biotech Stocks: Synergy Pharmaceuticals Inc (SGPY), Gilead Sciences, Inc. (GILD) SmarterAnalyst -5.18%
Jun-26-17 06:41PM  Synergy Pharmaceuticals Incs (SGYP) CIC Drug Set To Stay In Spotlight; BTIG Weighs In SmarterAnalyst
Jun-20-17 03:42PM  Why This Billionaire Just Bought Gilead Sciences, Synergy, and Valeant Stock Motley Fool
Jun-15-17 03:17PM  ETFs with exposure to Synergy Pharmaceuticals, Inc. : June 15, 2017 Capital Cube
Jun-14-17 02:18PM  Synergy Pharmaceuticals, Inc. Value Analysis (NASDAQ:SGYP) : June 14, 2017 Capital Cube
Jun-13-17 08:37AM  Rodman & Renshaw Roots for Synergy Pharmaceuticals Inc. (SGYP) Ahead of Promising Commercial Trajectory for Trulance SmarterAnalyst
08:26AM  Synergy Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SGYP-US : June 13, 2017 Capital Cube
Jun-12-17 12:40PM  Billionaire Israel Izzy Englander Bets on Three Biotech Stocks: Valeant Pharmaceuticals Intl Inc (VRX), Gilead Sciences, Inc. (GILD), Synergy Pharmaceuticals Inc (SGYP) SmarterAnalyst
Jun-07-17 09:00AM  Synergy Pharmaceuticals Announces Acceptance of Supplemental New Drug Application (sNDA) for TRULANCE (Plecanatide) for the Treatment of Adults with Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire
Jun-05-17 09:01AM  Is Ironwood's Growth About to Slow? Motley Fool -5.25%
08:00AM  Today's Research Reports on Stocks to Watch: Synergy Pharmaceuticals and Bioscrip Inc. Accesswire
Jun-03-17 11:13AM  Here's the Volatile Biotech Stock One Analyst Thinks Could Boom 175% TheStreet.com
Jun-02-17 01:03PM  Why Synergy Pharmaceuticals Shares Are Popping 16.7% Today Motley Fool +10.19%
May-30-17 08:30AM  Synergy Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference Business Wire
May-29-17 01:32PM  With Ardelyx's Fall, Does Synergy Now Have a Clear Path to Victory? Motley Fool
May-17-17 10:01AM  Allergan's Irritable Bowel Drug Viberzi Approved in Canada Zacks -6.33%
May-15-17 04:59PM  What Do the Ardelyx Numbers Mean for the Company? GuruFocus.com -8.31%
08:00AM  Synergy Pharmaceuticals and Durect Corporation Both Sail Higher on Trader Optimism Accesswire
May-10-17 06:44PM  Synergy Pharma reports 1Q loss Associated Press
04:54PM  Synergy Pharmaceuticals Reports First Quarter 2017 Financial Results and Business Update Business Wire
May-09-17 11:46AM  Synergy Scores Again: Trulance Product Meets Phase 3 Endpoints In Second Indication Benzinga
11:45AM  Synergy Pharmaceuticals to Present Positive TRULANCE (Plecanatide) Phase 3 Data at Digestive Disease Week (DDW) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) Business Wire
May-07-17 10:30AM  Synergy Presents New Insights at Digestive Disease Week (DDW) Examining Patient and Physician Perceptions and Experiences with Chronic Idiopathic Constipation (CIC) Business Wire
10:30AM  Synergy Pharmaceuticals to Present TRULANCE (Plecanatide) Phase 3 Data at Digestive Disease Week (DDW) for the Treatment of Adults with Chronic Idiopathic Constipation (CIC) with Moderate to Very Severe Bloating Business Wire
May-01-17 08:00AM  Synergy Pharmaceuticals to Highlight New Data for TRULANCE (Plecanatide) at Digestive Disease Week (DDW) Business Wire
Apr-24-17 08:00AM  Synergy Pharmaceuticals to Present at the 42nd Annual Deutsche Bank Healthcare Conference Business Wire
Apr-17-17 08:00AM  Synergy Pharmaceuticals Appoints Gary G. Gemignani as Chief Financial Officer Business Wire
Apr-13-17 09:21AM  Biotech Movers: Synergy, Biogen, Insys TheStreet.com
Apr-12-17 09:32AM  Biotech Movers: Neurocrine Biosciences Leaps on Drug Approval, Synergy Pharma Issued Three Patents TheStreet.com
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. Its lead product is plecanatide, a novel uroguanylin analog that is traded under the TRULANCE name for the treatment of chronic idiopathic constipation and irritable bowel syndrome. The company also develops dolcanatide to treat mild-to-moderate ulcerative colitis. Synergy Pharmaceuticals Inc. is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PAULSON & CO. INC.10% OwnerNov 10Sale2.828,750,00024,678,50015,312,368Nov 14 04:36 PM
PAULSON & CO. INC.10% OwnerAug 07Sale3.7726,28798,97224,062,368Aug 09 06:17 PM
BRANCACCIO JOHN PDirectorMay 26Buy3.596,50023,33530,444May 30 07:56 AM
JACOB GARY SChief Executive OfficerMay 26Buy3.525,68019,967402,679May 30 07:55 AM